// App-Quantinova.ai

10481 2014 BOS : Ultraearly Hematoma Growth: Multicenter External Validation of the Adjustment of Intracerebral Hemorrhage Volume by Onset-to-imaging Time

Researchers

Presenter

  • David Rodriguez-Luna

Principal Investigators

  • Jean-Martin Boulanger

  • Carlos S Kase

  • Gord Gubitz

  • Rohit Bhatia

  • Vasantha Padma

  • Jayanta Roy

  • Michael D Hill

  • Andrew M Demchuk

  • Matthew J Boyko

  • Carlos A Molina

  • Dar Dowlatshahi

  • Pilar Coscojuela

  • Richard I Aviv

  • Yolanda Silva

  • Imanuel Dzialowski

  • Cheemun Lum

  • Anna Czlonkowska

Medical Centers

  • Ottawa Hosp Res Inst, Univ of Ottawa, The Ottawa Hosp, Neuroradiology Section, Dept of Diagnostic Imaging, Ottawa, ON, Canada

  • Dalhousie Univ, Dept of Neurology, Halifax, NS, Canada

  • Univ of Calgary, Hotchkiss Brain Inst, Dept of Clinical Neurosciences and Radiology, Calgary, AB, Canada

  • Univ of Toronto, Sunnybrook Health Sciences Ctr, Div of Neuroradiology and Dept of Medical Imaging, Toronto, ON, Canada

  • Dept of Neurology, All India Inst of Medical Sciences, New Delhi, India

  • Ottawa Hosp Res Inst & Univ of Ottawa, Ottawa, ON, Canada

  • Vall -Hebron Univ Hosp, Barcelona, Spain

  • Univ of Sherbrooke, Charles LeMoyne Hosp, Montreal, QC, Canada

  • Dept of Neurology, Boston Medical Ctr, Boston, MA

  • Dr Josep Trueta Univ Hosp, Dept of Neurology, Inst -Investigacio Biomedica Girona IDIBGI Fndn, Girona, Spain

  • Neuroradiology Dept, Vall -Hebron Univ Hosp, Barcelona, Spain

  • Vall -Hebron Univ Hosp, Neurology Dept, Vall -Hebron Res Inst, Barcelona, Spain

  • AMRI Hospital, Kolkata, India

  • Dept of Neuroradiology, Univ Hosp Dresden, Dresden, Germany

  • nd Dept of Neurology, Institute of Psychiatry and Neurology of Warsaw, Warsaw, Poland

Locations

  • Canada

  • Poland

  • Germany

  • Spain

  • United States

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Intracerebral hemorrhage

  • Hematoma

Biomarkers

  • Collagen type IV alpha 2 chain

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • observational

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim